Oncology

Lab Space Frontier
Biotech

After ‘tough years,’ Frontier is ramping up clinical ambitions

Frontier CEO Chris Varma, Ph.D., told Fierce the biotech's team “have come back from” a tough period and want to ramp up their clinical ambitions.
Will Maddox Aug 27, 2026 9:50am
Revolution Medicines booth at ASCO 2026
Favicon Fierce Pharma

FDA greenlights RevMed’s pancreatic cancer gamechanger

Aug 26, 2026 11:30am
Connection together puzzle pieces Concept of business strategy collaboration
Favicon Fierce Pharma

McKesson acquires Maryland CRO for $2.25 billion

Aug 25, 2026 11:22am
Roy Maute

Pheast’s CEO has no regrets despite competitors gaining an edge

Aug 21, 2026 8:00am
Moderna booth at AACR 2026

Merck-Moderna cancer vax slows recurrence in ph. 3 trial

Aug 19, 2026 6:45am
Merck Co

Merck and Sarah Cannon team up for oncology trial efficiency

Aug 18, 2026 4:00pm
More News

Evaxion scraps tumor vaccine to focus on brain cancer candidate

Aug 17, 2026 9:18am

PDS halts ph. 3 cancer therapy to focus on colorectal contender

Aug 13, 2026 9:55am

Sobi pens $580M deal for Innate’s cancer drug before ph. 3 push

Aug 10, 2026 7:13am

Context ends bispecific trial to extend runway deeper into 2027

Aug 6, 2026 5:55am